asthma
chronic
obstruct
pulmonari
diseas
copd
common
inflammatori
diseas
airway
world
health
organ
estim
asthma
account
everi
death
worldwid
sullivan
preval
asthma
develop
countri
approxim
adult
even
higher
children
develop
countri
preval
lower
increas
rapidli
barn
case
copd
consensu
report
forecast
disord
rank
third
caus
mortal
world
global
initi
chronic
obstruct
lung
diseas
gold
acut
deterior
symptom
lung
function
often
result
respiratori
failur
socal
exacerb
import
sever
social
medic
burden
diseas
respiratori
viral
infect
common
usual
selflimit
ill
healthi
adult
major
caus
exacerb
patient
asthma
figur
andor
copd
figur
review
aim
summar
clinic
aspect
exacerb
asthma
copd
perspect
definit
exacerb
epidemiolog
pathophysiolog
special
focu
clinic
signific
presenc
respiratori
virus
asthma
copd
preval
chronic
pulmonari
diseas
character
chronic
airway
inflamm
airflow
limit
differ
two
diseas
mainli
cellular
molecular
featur
airway
inflamm
degre
revers
airway
flow
limit
gener
revers
airflow
limit
incomplet
copd
asthma
complet
airway
inflamm
asthma
character
allerg
phenotyp
dens
infiltr
eosinophil
helper
type
lymphocyt
associ
atop
statu
copd
mainli
accumul
neutrophil
cytotox
cell
activ
macrophag
caus
inhal
harm
substanc
smoke
respect
site
inflamm
asthma
involv
predominantli
larger
airway
copd
inflamm
affect
predominantli
small
airway
lung
parenchyma
character
irrevers
airway
narrow
fibrosi
around
small
airway
destruct
alveolar
wall
proteasemedi
degrad
barn
note
neutrophil
infiltr
could
recogn
bronchial
biopsi
specimen
well
eosinophil
sever
refractori
asthma
wenzel
et
al
describ
asthma
typic
character
chronic
allerg
inflammatori
airway
inflamm
associ
airway
hyperrespons
lead
recurr
episod
bronchial
obstruct
contrast
copd
character
persist
airflow
limit
usual
progress
ultim
result
respiratori
failur
therefor
difficult
differenti
clinic
two
disord
howev
determin
whether
patient
asthma
exacerb
copd
often
difficult
clinic
similar
tabl
summar
differ
two
diseas
tokuda
miyagi
provid
excel
review
rapid
physic
diagnosi
copd
patient
focus
inspect
palpat
percuss
auscult
special
maneuv
vital
sign
physic
examin
sound
expiratori
wheez
ident
asthma
copd
congest
heart
failur
pneumonia
use
distinguish
among
condit
kaplan
et
al
thu
physic
examin
rel
insensit
diagnosi
asthma
copd
characterist
physic
find
tokuda
miyagi
could
use
rapid
differenti
asthma
recent
understand
innat
immun
system
suggest
may
function
independ
adapt
immun
system
case
synergist
other
rel
contribut
two
system
may
explain
diseas
heterogen
among
asthmat
patient
might
occur
patient
copd
holtzman
long
argu
asthma
chronic
bronchiti
emphysema
could
consid
differ
express
one
diseas
entiti
view
call
dutch
hypothesi
kraft
still
debat
consensu
mani
similar
asthma
copd
bleecker
previou
studi
suggest
asthma
may
risk
factor
develop
copd
silva
et
al
coexist
asthma
copd
socal
overlap
syndrom
recent
attract
attent
overlap
syndrom
account
obstruct
airway
diseas
louie
et
al
show
frequent
sever
exacerb
higher
mortal
copd
alon
hosper
et
al
hardin
et
al
furthermor
previou
report
note
exacerb
asthma
copd
associ
acceler
loss
lung
function
qualiti
life
increas
healthcar
cost
mortal
thu
crucial
recogn
understand
clinic
featur
asthma
copd
patient
stabl
phase
also
exacerb
phase
associ
respiratori
viral
infect
johnston
sear
report
exacerb
asthma
copd
appear
season
predilect
similar
fashion
diagnosi
asthma
usual
defin
base
histori
variabl
peak
expiratori
flow
rate
pefr
andor
forc
expiratori
volum
least
either
therapi
spontan
clear
consensu
definit
asthma
exacerb
clinic
trial
usual
defin
sever
exacerb
need
treatment
system
corticosteroid
hospit
admiss
emerg
treatment
worsen
asthma
decreas
morn
peak
flow
baselin
two
consecut
day
byrn
et
al
accord
latest
nih
nation
asthma
educ
prevent
guidelin
asthma
exacerb
acut
subacut
episod
progress
worsen
short
breath
cough
wheez
chest
tight
combin
symptom
character
decreas
expiratori
airflow
object
measur
lung
function
spirometri
peak
flow
nation
asthma
educ
prevent
program
ident
definit
global
initi
asthma
guidelin
figur
howev
joint
task
forc
american
thorac
societi
european
respiratori
societi
recent
defin
asthma
exacerb
event
character
chang
patient
previou
statu
reddel
et
al
sever
exacerb
defin
event
requir
urgent
action
prevent
hospit
death
wherea
moder
exacerb
defin
statu
asthmat
patient
requir
prompt
chang
treatment
due
outsid
patient
usual
rang
daytoday
asthma
variat
mild
exacerb
defin
event
indistinguish
loss
asthma
control
reddel
et
al
figur
asthma
exacerb
common
femal
male
patient
higher
preval
asthma
adult
women
contrast
higher
preval
asthma
male
children
bjornson
mitchel
acut
asthma
exacerb
children
thought
relat
viral
rti
although
incid
adult
less
clear
previou
report
show
rti
associ
asthma
exacerb
adult
rang
teichtahl
et
al
johnston
et
al
atmar
et
al
hrv
johnston
et
al
atmar
et
al
tan
figur
despit
wide
differ
design
studi
suggest
viral
infect
involv
asthma
exacerb
among
adult
probabl
substanti
childhood
asthma
exacerb
anoth
report
also
show
viru
commonli
implic
asthma
exacerb
appear
hrv
murray
et
al
addit
hrv
respiratori
tract
virus
respiratori
syncyti
viru
rsv
influenza
virus
coronavirus
human
metapneumovirus
hmpv
parainfluenza
virus
piv
adenovirus
adv
bocavirus
detect
subject
asthma
exacerb
jackson
johnston
adult
requir
hospit
admiss
acut
sever
asthma
exacerb
period
viru
identifi
subject
hrv
influenza
commonli
identifi
infecti
agent
teichtahl
et
al
molecular
method
viral
detect
superior
sensit
specif
compar
cell
culturebas
method
mcerlean
et
al
set
acut
exacerb
reversetranscriptas
polymeras
chain
reaction
rtpcr
method
detect
virus
approxim
wheez
episod
schoolag
children
approxim
onehalf
threequart
acut
wheez
episod
adult
jackson
johnston
respect
sampl
collect
viral
detect
xiang
et
al
report
nasopharyng
secret
induc
sputum
acut
exacerb
asthma
adult
patient
equal
falsey
et
al
found
diagnost
yield
use
rtpcr
detect
viru
adult
hospit
respiratori
ill
superior
sputum
sampl
nose
throat
swab
howev
studi
limit
test
hrv
adv
use
anoth
report
show
sensit
rate
oropharyng
swab
op
nasopharyng
swab
np
nasopharyng
wash
npw
obtain
hospit
patient
acut
febril
lower
respiratori
tract
lrt
infect
respect
op
vs
np
npw
p
np
vs
npw
p
lieberman
et
al
taken
togeth
studi
appear
suggest
induc
sputum
npsnpw
better
method
identifi
respiratori
virus
regard
hrv
bronchoalveolar
lavag
bal
cell
posit
hrv
rna
infect
sampl
wherea
nasal
lavag
fluid
posit
patient
bal
fluid
posit
suggest
hrv
abl
infect
lower
airway
hrv
rna
larg
cellassoci
murray
et
al
eczema
famili
histori
asthma
domin
noninfecti
risk
factor
pediatr
asthma
trigger
adultonset
diseas
less
well
defin
caus
asthma
exacerb
describ
categor
note
clinician
recogn
season
trend
exacerb
wheez
asthma
adult
occur
week
later
children
suggest
household
transmiss
strain
johnston
et
al
hrv
document
throughout
year
predilect
late
spring
fall
nagel
et
al
wherea
rsv
detect
late
autumn
winter
figur
virus
import
virus
relev
asthma
develop
rsv
hrv
jackson
et
al
demonstr
larg
highrisk
cohort
children
increas
risk
asthma
year
age
wheez
first
year
life
rsv
odd
ratio
hrv
hrv
rsv
respiratori
syncyti
viru
year
age
children
infect
viru
year
age
nearli
infect
openshaw
exact
mechan
respiratori
viral
infect
caus
asthma
exacerb
remain
determin
respiratori
virus
implic
exacerb
larg
identifi
figur
role
sever
rsv
infect
risk
factor
asthma
adulthood
less
certain
still
studi
rsv
import
pathogen
young
children
account
sever
infantil
viral
bronchiol
andor
pneumonia
case
wheez
common
caus
hospit
admiss
winter
season
first
year
life
blanken
et
al
furthermor
studi
show
strongest
evid
human
rsvmediat
bronchiol
longterm
effect
use
palivizumab
human
monoclon
antibodi
rsv
f
protein
prevent
infect
rsv
infanc
children
year
rsv
piv
common
pathogen
wherea
older
children
rhinoviru
influenza
viru
preval
beasley
et
al
even
elderli
person
rsv
caus
pneumonia
falsey
et
al
exacerb
copd
acut
deterior
cardiac
diseas
contribut
substanti
excess
death
winter
season
olszewska
openshaw
human
rhinoviru
recent
studi
identifi
infect
hrv
predomin
respiratori
pathogen
associ
asthma
later
life
kusel
et
al
hrv
import
viru
type
associ
exacerb
asthma
lead
hospit
admiss
adult
children
johnston
et
al
tan
et
al
report
picornavirus
rhinovirusenteroviru
adv
commonli
identifi
nearfat
asthma
wherea
influenza
viru
predomin
copd
corn
et
al
found
detect
rate
hrv
asthmat
healthi
particip
similar
lrt
symptom
significantli
sever
longerlast
asthmat
group
healthi
group
thu
hrv
common
import
caus
exacerb
children
adult
johnston
et
al
rake
et
al
copenhav
et
al
messag
et
al
dougherti
fahi
olenec
et
al
jackson
et
al
hrv
classifi
three
speci
hrva
b
c
base
genet
properti
serotyp
identifi
molecular
epidemiolog
studi
suggest
hrva
c
major
preval
speci
wide
genet
diverg
fujitsuka
et
al
adenovirus
adenovirus
well
known
primari
caus
acut
respiratori
infect
particularli
young
children
adv
associ
virusrel
asthma
exacerb
mcerlean
et
al
caus
wide
varieti
clinic
syndrom
diarrhea
keratoconjunct
hemorrhag
cystiti
brodzinski
ruddi
demonstr
children
refractori
asthma
detect
adv
antigen
compar
control
macek
et
al
figur
parainfluenza
viru
previous
note
piv
one
common
pathogen
asthma
exacerb
children
year
adult
asthma
piv
infect
also
commonli
demonstr
sever
longitudin
studi
rti
identifi
less
commonli
studi
patient
seen
hospit
emerg
depart
atmar
et
al
virus
asthma
studi
describ
rel
low
level
influenza
virus
asthmat
patient
exacerb
approxim
virusrel
asthma
exacerb
sever
studi
indic
human
bocavirus
gendrel
et
al
vallet
et
al
hmpv
william
et
al
ong
et
al
associ
exacerb
asthma
especi
children
bacteria
mycoplasma
pneumonia
chlamydophila
pneumonia
found
frequent
airway
patient
asthma
healthi
patient
nisar
et
al
role
exacerb
less
clear
xepapadaki
et
al
previou
studi
report
mycoplasm
infect
children
wheez
henderson
et
al
identifi
exacerb
asthmat
children
requir
hospit
children
experienc
first
asthmat
attack
biscardi
et
al
howev
other
abl
confirm
observ
cunningham
et
al
specif
pathogen
includ
haemophilu
influenza
streptococcu
pneumonia
pseudomona
aeruginosa
moraxella
catarrhali
hrv
rsv
shown
increas
mucu
secret
recogn
asthma
copd
characterist
goblet
cell
hyperplasia
enhanc
mucu
secret
fahi
bisgaard
et
al
kraft
et
al
fungu
allerg
bronchopulmonari
aspergillosi
abpa
uniqu
form
asthma
caus
colon
lrt
vlahaki
aksamit
abpa
caus
exagger
helper
type
respons
ubiquit
mold
aspergillu
spp
colon
lead
allerg
andor
asthma
symptom
edward
et
al
factor
divers
etiolog
asthma
exacerb
well
known
includ
virus
allergen
dust
mite
pollen
anim
dander
smoke
gastroesophag
reflux
diseas
obes
rhinosinus
stress
occup
exposur
hormon
menstrual
asthma
drug
acetylsalicyl
acid
nonsteroid
antiinflammatori
drug
betablock
exercis
air
pollut
physician
awar
risk
factor
asthma
exacerb
dougherti
fahi
respiratori
viru
infect
affect
pathogenesi
asthma
bronchial
epitheli
cell
site
respiratori
viru
infect
replic
respiratori
viru
infect
induc
product
variou
cytokin
chemokin
caus
injuri
epitheli
cell
disrupt
tight
junction
inflammatori
process
may
amplifi
intrins
factor
suscept
gene
famili
histori
atopi
lung
develop
environment
factor
respiratori
viru
infect
allergen
exposur
smoke
air
pollut
etc
hashimoto
et
al
dougherti
fahi
studi
show
defici
interferon
ifn
product
respons
hrv
inocul
airway
epitheli
cell
cultur
asthmat
versu
normal
subject
holtzman
suggest
asthmat
patient
defici
perhap
precis
mechan
mechan
behind
defici
ifn
product
patient
remain
unknown
gener
upper
respiratori
tract
urt
symptom
includ
rhinorrhea
sneez
block
nose
sore
throat
hoars
voic
head
face
ach
chill
fever
lrt
symptom
includ
symptom
wheez
cough
short
breath
chest
tight
corn
et
al
tan
et
al
report
virusposit
patient
significantli
increas
frequenc
urt
symptom
rhinorrhea
sore
throat
fever
chill
malais
nicholson
et
al
report
adult
asthma
quarter
laboratoryconfirm
viral
chlamydi
acut
upper
respiratori
infect
associ
mean
decreas
peak
expiratori
flow
lmin
half
associ
mean
decreas
lmin
report
also
note
respiratori
pathogen
implic
almost
half
sever
asthma
exacerb
lmin
mean
decreas
peak
expiratori
flow
viral
infect
shown
enhanc
reactiv
lower
airway
magnitud
bronchoconstrict
respons
inhal
contractil
substanc
asthma
latter
effect
persist
sever
week
infect
present
lrt
symptom
cheung
et
al
accompani
decreas
peak
expiratori
flow
thu
physician
awar
decreas
peak
expiratori
flow
urt
lrt
symptom
associ
viral
infect
term
virusinduc
exacerb
uncommon
small
number
prospect
studi
conduct
far
nicholson
et
al
johnston
et
al
importantli
respiratori
infect
alway
result
exacerb
littl
evid
treat
prevent
infect
may
cure
prevent
exacerb
xepapadaki
papadopoulo
howev
anoth
studi
found
urt
infect
strongli
associ
exacerb
asthma
lead
hospit
admiss
adult
children
johnston
et
al
may
contribut
asthma
mortal
especi
set
hospit
admiss
specif
antivir
therapi
establish
except
influenza
viral
infect
recommend
person
asthma
copd
furthermor
regard
prevent
therapi
rsv
palivizumab
describ
commerci
avail
might
appropri
infant
young
children
congenit
heart
diseas
bronchopulmonari
dysplasia
prematur
week
gestat
dawsoncaswel
munci
blanken
et
al
state
palivizumab
treatment
healthi
preterm
infant
born
gestat
age
week
reduc
number
wheez
day
first
year
life
regard
sever
therapeut
strategi
would
need
taken
earli
cours
infect
maxim
effect
treatment
system
corticosteroid
antibiot
necessari
shortact
inhal
saba
follow
inhal
corticosteroid
ic
longact
combin
laba
therapi
kerstjen
et
al
report
addit
longact
muscarin
antagonist
lama
therapi
tiotropium
known
cornerston
copd
treatment
significantli
increas
time
first
exacerb
improv
poorli
control
asthmat
patient
standard
therapi
ic
laba
similarli
tiotropium
improv
lung
function
reduc
chanc
rescu
inhal
saba
patient
overlap
syndrom
magnussen
et
al
exacerb
copd
event
character
acut
increas
respiratori
symptom
beyond
normal
daytoday
variat
vestbo
et
al
clinician
research
alway
keep
mind
exacerb
copd
neither
defin
consist
match
individu
studi
definit
exacerb
roughli
divid
two
group
eventbas
exacerb
symptombas
exacerb
depend
patient
symptom
clinic
event
respect
symptom
defin
includ
dyspnea
cough
sputum
volum
purul
clinic
event
defin
statu
requir
addit
treatment
system
antimicrobi
steroid
without
admiss
diseas
pneumonia
congest
heart
failur
pulmonari
embol
mimic
andor
aggrav
exacerb
gener
exclud
exacerb
copd
clinic
cours
copd
well
asthma
punctuat
exacerb
character
sudden
symptom
worsen
beyond
expect
daili
variat
exacerb
import
event
clinic
cours
copd
associ
signific
mortal
inhospit
mortal
rate
patient
admit
hospit
exacerb
copd
increas
year
followup
groenewegen
et
al
exacerb
correl
acceler
loss
lung
function
qualiti
life
increas
healthcar
cost
seemung
et
al
donaldson
et
al
miravitl
et
al
previou
studi
show
annual
rate
eventbas
exacerb
copd
per
patient
per
year
calverley
et
al
tashkin
et
al
wedzicha
et
al
seemung
et
al
hurst
et
al
inspir
studi
show
rate
symptombas
exacerb
two
time
high
eventbas
exacerb
seemung
et
al
eclips
studi
exacerb
rate
per
person
patient
moder
diseas
gold
stage
sever
diseas
gold
stage
hurst
et
al
thu
rate
exacerb
seem
depend
diseas
sever
gold
stage
howev
particularli
worth
note
eclips
studi
show
subgroup
copd
patient
appear
suscept
exacerb
irrespect
gold
stage
factor
exacerb
sever
environment
factor
season
inhal
harm
substanc
epidem
peak
exacerb
copd
note
late
fall
winter
fashion
adult
asthma
johnston
sear
report
exacerb
predominantli
caus
bacteri
viral
respiratori
infect
figur
air
pollut
minor
contribut
previou
studi
show
bacteria
h
influenza
pneumonia
moraxella
catarrhali
p
aeruginosa
respiratori
virus
hrv
rsv
influenza
viru
hmpv
coronaviru
adv
recogn
exacerb
bacteria
h
influenza
pneumonia
moraxella
catarrhali
p
aeruginosa
also
detect
stabl
patient
sapey
stockley
sethi
murphi
strain
bacteria
chang
among
speci
emerg
bacteria
might
caus
inflamm
lung
copd
patient
result
exacerb
sethi
et
al
role
atyp
respiratori
pathogen
mycoplasma
pneumonia
c
pneumonia
exacerb
copd
poorli
recogn
sapey
stockley
sethi
murphi
perotin
et
al
hand
blasi
et
al
show
c
pneumonia
may
associ
exacerb
copd
virus
hrv
rsv
influenza
viru
higher
preval
patient
exacerb
copd
stabl
patient
rohd
et
al
wilkinson
et
al
human
rhinoviru
detect
viru
exacerb
copd
hrv
infect
alon
also
coinfect
hrv
bacteria
may
caus
exacerb
wilkinson
et
al
mallia
et
al
report
experiment
hrv
infect
show
sever
prolong
lower
respiratori
symptom
airway
obstruct
neutrophil
airway
inflamm
copd
patient
control
subject
state
rhinoviru
infect
led
elev
neutrophil
elastas
associ
reduct
antimicrobi
peptid
secretori
leukoproteas
inhibitor
elafin
reduct
antimicrobi
peptid
predispos
secondari
bacteri
infect
mallia
et
al
previou
report
show
copd
exacerb
may
associ
impair
host
respons
hrv
exampl
reduc
ifn
product
observ
copd
patient
compar
control
subject
may
associ
mechan
viral
subsequ
bacteri
infect
relat
sever
exacerb
impair
humor
immun
also
relat
exacerb
copd
patient
hospit
copd
exacerb
lower
serum
level
rhinovirusspecif
antibodi
hospit
copd
exacerb
yerkovich
et
al
thymic
stromal
lymphopoietin
tslp
key
proallerg
cytokin
recent
link
asthma
redhu
gounni
addit
genomewid
associ
studi
show
polymorph
near
within
tslp
gene
associ
variou
allerg
diseas
includ
bronchial
asthma
hirota
et
al
ober
yao
tslp
may
contribut
exacerb
pathogen
effect
hrv
infect
via
tolllik
receptor
tlr
pathway
calven
et
al
respiratori
syncyti
viru
detect
stabl
exacerb
case
copd
rsv
detect
stabl
copd
patient
might
associ
insidi
airway
inflamm
acceler
declin
wilkinson
et
al
howev
confirm
anoth
studi
falsey
et
al
rsv
increas
express
surfac
airway
epitheli
cell
associ
increas
sensit
doublestrand
rna
relat
infect
groskreutz
et
al
influenza
viru
associ
mortal
morbid
chronic
lung
diseas
harper
et
al
metaanalysi
show
influenza
vaccin
prevent
exacerb
copd
patient
pool
et
al
reduc
mortal
morbid
elderli
person
nichol
et
al
antivir
treatment
neuraminidas
inhibitor
may
reduc
sever
diseas
kaiser
et
al
thu
treatment
prevent
influenza
recommend
copd
patient
harper
et
al
greenberg
et
al
investig
viral
infect
without
copd
longitudin
cohort
studi
demonstr
annual
symptomat
document
respiratori
viral
infect
rate
similar
copd
agematch
control
respect
howev
copd
patient
offic
visit
hospit
control
note
mallia
et
al
confirm
find
human
experiment
studi
found
signific
differ
frequenc
success
hrv
infect
copd
control
group
group
experiment
inocul
hrv
respiratori
symptom
declin
lung
function
sever
copd
group
control
group
sever
studi
suggest
respiratori
virusassoci
exacerb
critic
event
due
caus
viraldetect
exacerb
show
larger
declin
lung
function
longer
recoveri
time
nonvir
exacerb
seemung
et
al
bafadhel
et
al
describ
chapter
hrv
respiratori
viral
infect
exacerb
copd
patient
tend
provok
secondari
bacteri
infect
viral
sequenti
bacteri
infect
may
associ
sever
respiratori
symptom
wilkinson
et
al
harper
et
al
mallia
et
al
shown
tabl
patholog
featur
copd
fibrosi
around
small
airway
involv
sever
differ
cell
neutrophil
macrophag
lymphocyt
destruct
lung
parenchyma
neutrophil
found
associ
stabl
exacerb
copd
hogg
et
al
papi
et
al
chang
neutrophil
count
exacerb
sputum
peripher
blood
found
relat
valu
level
tumor
necrosi
factoralpha
interleukin
il
sputum
associ
neutrophil
inflamm
keat
et
al
especi
patient
suffer
frequent
exacerb
persist
higher
system
creactiv
protein
crp
level
may
explain
greater
declin
lung
function
perera
et
al
inflammatori
cytokin
sputum
exacerb
found
elev
regardless
whether
infect
viral
bacteri
aaron
et
al
level
higher
exacerb
stabl
eosinophil
consid
characterist
cell
asthma
also
detect
exacerb
copd
saetta
et
al
inde
papi
et
al
demonstr
virusassoci
exacerb
copd
patient
relat
increas
eosinophil
count
level
eosinophil
cation
protein
furthermor
bafadhel
et
al
show
serum
cxc
motif
chemokin
implic
potent
predict
maker
virusassoci
exacerb
known
protein
inhal
bronchodil
lama
laba
main
pharmacolog
therapi
stabl
copd
patient
tashkin
et
al
wedzicha
et
al
vestbo
et
al
although
vogelmei
et
al
report
tiotropium
lama
treat
group
lower
exacerb
rate
salmeterol
laba
treat
group
headtohead
studi
lama
laba
treatment
decreas
exacerb
rate
improv
lung
function
healthrel
qualiti
life
tashkin
et
al
found
combin
lamalaba
therapi
improv
pulmonari
function
respiratori
symptom
better
lama
therapi
alon
ic
main
treatment
asthma
also
prescrib
copd
patient
may
reduc
airway
inflamm
decreas
exacerb
rate
moder
sever
copd
patient
calverley
et
al
treatment
macrolid
antibiot
report
prevent
copd
exacerb
improv
patient
qualiti
life
symptom
especi
patient
frequent
exacerb
albert
et
al
yamaya
et
al
although
intervent
could
lead
unfavor
event
increas
preval
macrolideresist
pathogen
cardiac
toxic
estim
exacerb
copd
due
respiratori
viral
andor
bacteri
infect
thu
major
pharmacolog
compon
manag
exacerb
copd
includ
saba
shortcours
system
glucocorticoid
antibiot
vestbo
et
al
howev
antivir
therapi
rare
prescrib
specif
antivir
therapi
exist
except
influenza
viru
rsv
treatment
influenza
appear
appropri
patient
copd
harper
et
al
util
treatment
rsv
confirm
adult
doubt
system
corticosteroid
treatment
affect
clinic
cours
respiratori
viral
infect
lee
et
al
show
shortcours
system
steroid
treatment
affect
viral
load
shed
humor
immun
may
diminish
steroid
treatment
research
shown
lama
may
affect
viral
infect
tiotropium
one
lama
may
inhibit
hrv
rsv
infect
reduc
level
intercellular
adhes
bind
site
hrv
iesato
et
al
yamaya
et
al
associ
viru
infect
asthma
andor
copd
review
signific
viral
infect
well
effect
clinic
cours
discuss
hrv
rsv
major
caus
exacerb
asthma
copd
patient
frequenc
viral
detect
asthma
copd
patient
appear
similar
healthi
subject
effect
clinic
cours
differ
asthma
copd
patient
tend
sever
persist
respiratori
symptom
decreas
pulmonari
function
mortal
may
increas
sinc
discrimin
asthma
copd
difficult
especi
exacerb
whenev
clinician
encount
patient
obstruct
airway
diseas
suspect
multidisciplinari
assess
requir
diagnosi
clinic
find
asthma
copd
socal
overlap
syndrom
commonli
recogn
gener
practic
virusassoci
exacerb
diseas
may
lead
poor
prognosi
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
